FREE Account Opening + No Clearing Fees
Loading...

Bajaj Auto Buyback 2024 vs Zydus Lifesciences Buyback 2024

Comparision between Bajaj Auto Buyback 2024 and Zydus Lifesciences Buyback 2024.

Buyback Details

Bajaj Auto Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Zydus Lifesciences Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.

  Bajaj Auto Limited Zydus Lifesciences Limited
Logo Bajaj Auto Buyback 2024 Logo Zydus Lifesciences Buyback 2024 Logo
Type of Buyback Tender Offer Tender Offer
Listing At BSE, NSE BSE, NSE
Face Value ₹10 per share ₹1 per share
Buyback Price ₹10000 per share ₹1005 per share
Issue Size 40,00,000 shares 59,70,149 shares
Issue Size (Amount) ₹4,000.00 Crores ₹600.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders7 Equity Shares out of every 27 Fully paid-up Equity Shares held on the Record Date.600,000.00
General Category for all other Eligible Shareholders1 Equity Shares out of every 82 Fully paid-up Equity Shares held on the Record Date.3,400,000.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders6 Equity Shares out of every 67 Fully paid-up Equity Shares held on the Record Date.895,523.00
General Category for all other Eligible Shareholders2 Equity Shares out of every 395 Fully paid-up Equity Shares held on the Record Date.5,074,626.00
Registrar Kfin Technologies Limited Link Intime India Private Ltd
Lead Managers Jm Financial Limited ICICI Securities Limited
Necessity of the buyback

The financial strategy of the Company is aimed at driving the sustainable growth of its business and enhancing the returns for its Shareholders. The growth of the business, robust cash generation and strong balance sheet position allows the Company to reward its shareholders from time to time, as in the current instance, while retaining sufficient capital for growth investments, and opportunities. The Buyback reinforces the Company's commitment to its shareholders by returning surplus cash to them in an effective and efficient manner, which in turn will improve its earnings per share and return on equity.

The Buyback will help the company to distribute a part of the surplus cash to its shareholders holding equity shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in the longer term, and improving the return on equity.

Buyback Timetable

Bajaj Auto Buyback 2024 and Zydus Lifesciences Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Bajaj Auto Buyback 2024 Buyback record date is Feb 29, 2024. Zydus Lifesciences Buyback 2024 Buyback record date is Feb 23, 2024.

  Bajaj Auto Limited Zydus Lifesciences Limited
Record Date Feb 29, 2024 Feb 23, 2024
Offer Open Date Mar 06, 2024 Feb 29, 2024
Offer Closure Date Mar 13, 2024 Mar 06, 2024
Last date for receipt of tender forms Mar 13, 2024 Mar 06, 2024
Finalisation of buyback Mar 19, 2024 Mar 13, 2024
Last Date for settlment of bids Mar 20, 2024 Mar 14, 2024
Last Date for extinguishment of shares Mar 26, 2024 Mar 26, 2024

Financial Details and Other Relevent Information

Comparison of Bajaj Auto Buyback 2024 and Zydus Lifesciences Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Bajaj Auto Limited Zydus Lifesciences Limited
Financial

Bajaj Auto Limited Financial Information (Restated Consolidated)

Bajaj Auto Limited's revenue increased by 9.34% and profit after tax (PAT) dropped by -1.71% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets35,136.4535,111.2133,601.71
Revenue34,391.5137,642.9034,428.8529,017.54
Profit After Tax5,696.816,060.216,165.874,857.02
Reserves and Surplus25,142.9026,379.4324,912.89
Amount in ₹ Crore

Zydus Lifesciences Limited Financial Information (Restated Consolidated)

Zydus Lifesciences Limited's revenue increased by 17.07% and profit after tax (PAT) rose by 78.25% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Revenue9,553.508,160.607,869.30
Profit After Tax1,529.20857.901,476.20
Net Worth17,515.8016,999.6012,992.30
Reserves and Surplus1,801.75
Total Borrowing1,163.204,196.004,583.50
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2024 8325.05 7655.75 7857.95
Jan-2024 7667.55 6665.05 7171.90
Dec-2023 6797.25 6046.05 6324.41

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 765.50 684.75 719.52
Dec-2023 696.65 630.15 657.86
Nov-2023 649.00 570.35 619.04
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2024 8325.80 7653.85 7857.23
Jan-2024 7663.55 6662.50 7171.38
Dec-2023 6801.00 6046.60 6323.84

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 766.00 685.00 719.72
Dec-2023 696.50 630.00 658.11
Nov-2023 649.05 630.00 619.14

Comments

Add a public comment...